Reply to: "Special editorial: When prescribing Janus Kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communication".

J Am Acad Dermatol

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

Published: August 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jaad.2022.03.061	DOI Listing

Publication Analysis

reply "special

"special editorial

editorial prescribing

prescribing janus

janus kinase

kinase inhibitors

inhibitors dermatologic

dermatologic conditions

conditions mindful

mindful food

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!